Indo-Bangla Pharmaceuticals Limited announced earnings results for the first quarter ended September 30, 2020. For the first quarter, the company announced sales was BDT 210.445 million compared to BDT 214.684 million a year ago. Operating income was BDT 52.603 million compared to BDT 60.399 million a year ago. Net income was BDT 37.712 million compared to BDT 44.155 million a year ago. Basic earnings per share from continuing operations was BDT 0.34 compared to BDT 0.4 a year ago.